Social Skills Training in Refractory Schizophrenia (SST)

November 27, 2009 updated by: University of Sao Paulo

Evaluation of Social Skills Training in Reducing Negative Symptoms in Patients With Refractory Schizophrenia

Objective Primary:

To evaluate the efficacy of social skills training in reducing negative symptoms in patients with refractory schizophrenia, in comparison with control (befriending group).

Secondary:

To evaluate changes in social functioning.

To evaluate the effect of SST in other dimensions of psychopathology: positive symptoms, depression and general psychopathology.

To evaluate the impact of SST in cognition.

Hypothesis Social skills training is more effective than control group (Befriending) in reducing negative symptoms in patients with refractory schizophrenia.

Study Overview

Detailed Description

In schizophrenia positive symptoms can be improved with an antipsychotic treatment. However there is a subgroup of patients who have a predominance of persistent negative symptoms that do not respond to antipsychotic treatment, such as blunted affect , emotional and social withdrawal, and there is evidence that such symptoms can improve with psychosocial interventions.

The objective of this study is to evaluate the efficacy of Social Skills Training on negative symptoms in patients with refractory schizophrenia by means of a randomized, single-blind controlled trial with the duration of a year, including, follow up.

This study will be conducted in two groups: one group will receive social skills training (N=46) and a control group (N=46) will attend the same number of sessions, but without intervention of the therapists (befriending).

Psychiatric, psychological and neuropsychological aspects will be evaluated at baseline, after 20 weeks and 6 months after the end of the intervention.

The scales that will be used for the psychiatric assessments are: PANSS (reduction of 20% in the negative subscale), CGI, CALGARY, SDS, and PSP, As well as the Social Skills Inventory IHS. The neuropsychological assessment will have groups of scales to measure: Attention, Memory, Executive Functions, Estimated Intellectual Efficiency and a ToM. For statistical , the repeated measure ANOVA will be used, as well as the effect size and number needed to treat.

Study Type

Interventional

Enrollment (Anticipated)

92

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Helio Elkis, MD PhD
  • Phone Number: + 55 11 30697531
  • Email: helkis@usp.br

Study Contact Backup

Study Locations

      • São Paulo, Brazil, 05403000
        • Recruiting
        • Instituto de Psiquiatria do HCFMUSP
        • Contact:
        • Principal Investigator:
          • Helio Elkis, PhD MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of schizophrenia can´t not be over 10 years old.
  • Age between 18 and 55 years old.
  • A minimum of 16 in negative subscale of PANSS.
  • A score 4 in at least 3 of the following symptoms:

    • blunted affect
    • social withdrawal
    • rapport
    • passive social withdrawal
    • lack of spontaneity
    • motor retardation
    • active social avoidance
  • Stable disease, in use of clozapine, without recent hospitalization.

Exclusion Criteria:

  • Comorbid substance use.
  • Axis I comorbidity.
  • History of head trauma or neurological disease.
  • Clinical problems which can affect central nervous system.
  • Mental retardation.
  • Patients treated with other antipsychotic than clozapine.
  • Patients who underwent other psychosocial treatments.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1

Group of behaviors by which someone express feelings, attitudes, wishes,opinions and rights , in an adequate manner regarding situation and context.

Social skills are the substrate for social competence, which is the ability to find and legitimate relevant and personal goals

A program developed during 20 weeks according to adapted BELLACK 's manual (1997),including sessions in group one hour per week.
Other Names:
  • Social Skills Training and Control group without active intervention.
No Intervention: 2
Control group will attend the same number of sessions, but without intervention of the therapists
A program developed during 20 weeks according to adapted BELLACK 's manual (1997),including sessions in group one hour per week.
Other Names:
  • Social Skills Training and Control group without active intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Response: at least 20% decrease at PANSS - negative subscale after 20 weeks, in comparison with baseline, maintained at 26 weeks follow-up.
Time Frame: 20 weeks treatment
20 weeks treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
Improvement at PSP scores
Time Frame: 20 weeks after treatment
20 weeks after treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Helio Elkis, MD PhD, Departamento de Psiquiatria da FMUSP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2009

Primary Completion (Anticipated)

August 1, 2011

Study Completion (Anticipated)

August 1, 2011

Study Registration Dates

First Submitted

November 14, 2008

First Submitted That Met QC Criteria

November 14, 2008

First Posted (Estimate)

November 17, 2008

Study Record Updates

Last Update Posted (Estimate)

November 30, 2009

Last Update Submitted That Met QC Criteria

November 27, 2009

Last Verified

November 1, 2009

More Information

Terms related to this study

Other Study ID Numbers

  • SST

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Schizophrenia and Disorders With Psychotic Features

Clinical Trials on Social Skills Training

3
Subscribe